Herbas VPB

Print
EN | LT
LT - METHODS FOR ASSESSING RESPONSIVENESS OF CANCER CELLS TO LENALIDOMIDE, THALIDOMIDE, AND/OR POMALIDOMIDE
EN - METHODS FOR ASSESSING RESPONSIVENESS OF CANCER CELLS TO LENALIDOMIDE, THALIDOMIDE, AND/OR POMALIDOMIDE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/454
A61P 35/00
G01N 33/574
European patent
(11) Number of the document 2683412
(13) Kind of document T
(96) European patent application number 12757445.7
Date of filing the European patent application 2012-03-08
(97) Date of publication of the European application 2014-01-15
(45) Date of publication and mention of the grant of the patent 2017-05-03
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2012/028285
Date 2012-03-08
PCT application publication
(87) Number WO 2012/125405
Date 2012-09-20
Priority applications
(30) Number Date Country code
201161452027 P 2011-03-11 US
Inventors
(72)
STEWART, Alexander Keith, US
BERGSAGEL, Peter, US
FONSECA, Rafael, US
BRAGGIO, Esteban, US
Grantee
(73) MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, 200 First Street S.W., Rochester, MN 55905, US
Title
(54) METHODS FOR ASSESSING RESPONSIVENESS OF CANCER CELLS TO LENALIDOMIDE, THALIDOMIDE, AND/OR POMALIDOMIDE
  METHODS FOR ASSESSING RESPONSIVENESS OF CANCER CELLS TO LENALIDOMIDE, THALIDOMIDE, AND/OR POMALIDOMIDE
Last update date 2021-04-30